Platelet-rich plasma as an effective biological therapy in early-stage knee osteoarthritis: One year follow up
SICOT-J · 2021 · 7 · 6
DOI: 10.1051/sicotj/2021003 ↗Kurz gefasst
Fachartikel in der Zeitschrift SICOT-J, online erschienen am 01.03.2021. Verfasst von Deepak Rai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Senior Resident, Department of Orthopaedics, Trauma Center, BHU, 221005 Varanasi, India. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
PRP is produced by centrifugation of whole blood containing highly concentrated platelets, associated growth factors, and other bioactive agents which has been shown to provide some symptomatic relief in early knee osteoarthritis (OA). The principal objective of our study was to evaluate the effectiveness and safety of standardized intra-articular injection of autologous PRP in early osteoarthritis knee.
Methods
A total of 98 eligible symptomatic patients received two injections of standardized PRP 3 weeks apart. Clinical outcomes were evaluated using the VAS and Western Ontario and McMaster Universities Arthritis Index (WOMAC) questionnaire before treatment and at 6 weeks, 3 months, 6 months, and 1 year after treatment. Secondary objectives were s afety (side effects), and the effect of PRP on the different grades of knee degeneration.
Results
There was a statistically significant improvement in mean VAS and WOMAC scores at 6 weeks, 3 months, 6 months, and slight loss of improvement at 1 year follow-up. There was also a correlation between the degree of degeneration and improvement in the mean scores. The decrease in mean pain score is more in grades 1 and 2 (early OA) than in grade 3. The intraarticular injection is safe, with no major complications.
Conclusion
PRP is a safe and effective biological regenerative therapy for early OA Knees. It provides a significant clinical improvement in patients with some loss of improvement with time. More studies will be needed to confirm our findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Senior Resident, Department of Orthopaedics, Trauma Center, BHU, 221005 Varanasi, India.
- Junior Resident, Department of Pediatrics, JNMC, AMU, 202002 Aligarh, India.
- Professor, Department of Orthopaedics, Rohilkhand Medical College, 243006 Bareilly, India.
- Professor, Department of Orthopaedics, S.S. Hospital, BHU, 221005 Varanasi, India.
ORCID-Profile: Ajit Singh
Zitieren
APA
Rai, D., Singh, J., Somashekharappa, T., & Singh, A. (2021). Platelet-rich plasma as an effective biological therapy in early-stage knee osteoarthritis: One year follow up. SICOT-J, 7, 6. https://doi.org/10.1051/sicotj/2021003
Vancouver
Rai D, Singh J, Somashekharappa T, Singh A. Platelet-rich plasma as an effective biological therapy in early-stage knee osteoarthritis: One year follow up. SICOT-J. 2021;7:6. doi:10.1051/sicotj/2021003
BibTeX
@article{Rai2021,
author = {Rai, Deepak and Singh, Jyotsana and Somashekharappa, Thimmappa and Singh, Ajit},
title = {Platelet-rich plasma as an effective biological therapy in early-stage knee osteoarthritis: One year follow up},
journal = {SICOT-J},
year = {2021},
volume = {7},
pages = {6},
doi = {10.1051/sicotj/2021003}
}
EUVIMED